PrimeInvestor - Articles and Reports

Just as it seemed like the sector had turned a corner, President Trump’s talk about imposing tariffs of 25% on imports from India has made pharma sector investors sick with worry prompting a sell-off. This tariff, if it does come into force, will affect some players more than others. One of the companies that it […]

This company is turning a boring commodity business into a wealth creation machine for investors!

The next big thing in India’s wellness story!

A stable consumer play to ride through an environment of moderating earnings growth.

After careful analysis, we think the present correction is an opportunity to average down your cost.